Estimating a drug’s elimination rate-constant or half-life from a single blood sample

A practical approach with particular benefits for critically ill/vulnerable patients

Greg Scutt, Marcus Allen, David Waxman

Research output: Contribution to journalArticleResearchpeer-review

Abstract

In this paper we present a mathematical solution that allows the elimination rate-constant or half life of a drug to be estimated from a single blood drug measurement. This is of great utility in clinical areas involving care of criticallly ill or vulnerable patients, where providing more than one blood sample can involve significant risks. The calculations used in our approach, based solely on a single sample, do not require complex pharmacokinetic software, but instead can be simply performed at the patient’s bedside using standard personal computing tools. The proposed method allows a personalised estimate of the drug’s half life, which is preferable to using population averages, or using estimates based on proxy markers of lagging organ function, which are both indirect and generally inaccurate for a patient with confounding factors.
Original languageEnglish
Article number103996
JournalBioSystems
Volume184
DOIs
Publication statusPublished - 29 Jul 2019

Fingerprint

Critical Illness
Half-Life
Pharmaceutical Preparations
Proxy
Software
Pharmacokinetics
Population

Keywords

  • Mathematical models
  • Personalised medicine
  • Pharmacokinetics
  • Steady state and transient drug concentration
  • Therapeutic drug monitoring

Cite this

@article{9a102404078b4140a0be9ab2e564ac7c,
title = "Estimating a drug’s elimination rate-constant or half-life from a single blood sample: A practical approach with particular benefits for critically ill/vulnerable patients",
abstract = "In this paper we present a mathematical solution that allows the elimination rate-constant or half life of a drug to be estimated from a single blood drug measurement. This is of great utility in clinical areas involving care of criticallly ill or vulnerable patients, where providing more than one blood sample can involve significant risks. The calculations used in our approach, based solely on a single sample, do not require complex pharmacokinetic software, but instead can be simply performed at the patient’s bedside using standard personal computing tools. The proposed method allows a personalised estimate of the drug’s half life, which is preferable to using population averages, or using estimates based on proxy markers of lagging organ function, which are both indirect and generally inaccurate for a patient with confounding factors.",
keywords = "Mathematical models, Personalised medicine, Pharmacokinetics, Steady state and transient drug concentration, Therapeutic drug monitoring",
author = "Greg Scutt and Marcus Allen and David Waxman",
year = "2019",
month = "7",
day = "29",
doi = "10.1016/j.biosystems.2019.103996",
language = "English",
volume = "184",
journal = "BioSystems",
issn = "0303-2647",

}

TY - JOUR

T1 - Estimating a drug’s elimination rate-constant or half-life from a single blood sample

T2 - A practical approach with particular benefits for critically ill/vulnerable patients

AU - Scutt, Greg

AU - Allen, Marcus

AU - Waxman, David

PY - 2019/7/29

Y1 - 2019/7/29

N2 - In this paper we present a mathematical solution that allows the elimination rate-constant or half life of a drug to be estimated from a single blood drug measurement. This is of great utility in clinical areas involving care of criticallly ill or vulnerable patients, where providing more than one blood sample can involve significant risks. The calculations used in our approach, based solely on a single sample, do not require complex pharmacokinetic software, but instead can be simply performed at the patient’s bedside using standard personal computing tools. The proposed method allows a personalised estimate of the drug’s half life, which is preferable to using population averages, or using estimates based on proxy markers of lagging organ function, which are both indirect and generally inaccurate for a patient with confounding factors.

AB - In this paper we present a mathematical solution that allows the elimination rate-constant or half life of a drug to be estimated from a single blood drug measurement. This is of great utility in clinical areas involving care of criticallly ill or vulnerable patients, where providing more than one blood sample can involve significant risks. The calculations used in our approach, based solely on a single sample, do not require complex pharmacokinetic software, but instead can be simply performed at the patient’s bedside using standard personal computing tools. The proposed method allows a personalised estimate of the drug’s half life, which is preferable to using population averages, or using estimates based on proxy markers of lagging organ function, which are both indirect and generally inaccurate for a patient with confounding factors.

KW - Mathematical models

KW - Personalised medicine

KW - Pharmacokinetics

KW - Steady state and transient drug concentration

KW - Therapeutic drug monitoring

UR - http://www.scopus.com/inward/record.url?scp=85071941343&partnerID=8YFLogxK

U2 - 10.1016/j.biosystems.2019.103996

DO - 10.1016/j.biosystems.2019.103996

M3 - Article

VL - 184

JO - BioSystems

JF - BioSystems

SN - 0303-2647

M1 - 103996

ER -